NCT00892944View on ClinicalTrials.gov

An Open Label Positron Emission Tomography (PET) Study to Determine Central mGluR5 Receptor Occupancy of AZD2516

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

April 30, 2009

Study Completion Date

October 31, 2009

Conditions

Healthy

Interventions

DRUG

AZD2516

Fractionated single oral dose

Trial Locations (1)

Unknown

Research Site, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY